XML 84 R69.htm IDEA: XBRL DOCUMENT v3.25.0.1
Revenue Recognition - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]                      
Revenue $ 646,542 $ 621,401 $ 647,145 $ 639,653 $ 556,055 $ 511,015 $ 469,136 $ 427,690 $ 2,554,741 [1] $ 1,963,896 [1] $ 1,352,013 [1]
Evolent Health Services Segment                      
Disaggregation of Revenue [Line Items]                      
Revenue                 2,554,741 1,963,896 1,352,013
Evolent Health Services Segment | Performance Suite                      
Disaggregation of Revenue [Line Items]                      
Revenue                 1,801,879 1,214,661 808,642
Evolent Health Services Segment | Specialty Technology and Services Suite                      
Disaggregation of Revenue [Line Items]                      
Revenue                 338,306 296,366 51,898
Evolent Health Services Segment | Administrative Services                      
Disaggregation of Revenue [Line Items]                      
Revenue                 238,036 296,244 407,523
Evolent Health Services Segment | Cases                      
Disaggregation of Revenue [Line Items]                      
Revenue                 176,520 156,625 83,950
Evolent Health Services Segment | Medicaid                      
Disaggregation of Revenue [Line Items]                      
Revenue                 862,401 785,053 559,362
Evolent Health Services Segment | Medicare                      
Disaggregation of Revenue [Line Items]                      
Revenue                 1,045,921 708,853 458,413
Evolent Health Services Segment | Commercial and other                      
Disaggregation of Revenue [Line Items]                      
Revenue                 $ 646,419 $ 469,990 $ 334,238
[1] See Note 19 for amounts attributable to unconsolidated related parties included in these line items.